Skip to main content
. 2014 Oct 29;15(12):1635–1645. doi: 10.4161/15384047.2014.964087

Figure 2.

Figure 2.

Inhibition on VEGF stimulated activation of KDR and VEGFR3. (A) Fruquintinib inhibited VEGF-A-stimulated KDR phosphorylation and downstream signaling in HUVEC. (b) Fruquintinib abrogated VEGF-A-stimulated KDR phosphorylation and downstream signaling in HEK-293-KDR cell line. (C) Fruquintinib suppressed VEGF-C stimulated VEGFR3 phosphorylation in VEGF-C-stimulated HLEC.